The safety aspect of robotic systems in drug discovery is a significant advantage, it minimizes the reliance on human involvement, and these systems reduce the potential for human error and contamination in the experimental process. This enhanced safety leads to increased reliability and reproducibility of experimental results, which are crucial factors in the drug discovery field. The assurance of consistent and accurate outcomes enhances the drug discovery market attractiveness by improving the efficiency, credibility, and success rates of drug discovery efforts.
According to Data Bridge Market Research, the Robotics in Drug Discovery Market accounted for a CAGR of around 12.40% for the forecast period of 2022-2029.
“Rising technological advancements and development in the field of robotics”
The robotics in drug discovery market is being propelled by the continuous advancements and developments in technology. With cutting-edge technologies such as artificial intelligence, machine learning, and automation, robotics is revolutionizing the drug discovery process. These advancements enable the efficient screening of large compound libraries, accurate sample handling, and precise data analysis, leading to accelerated drug discovery timelines and improved success rates. Minimizing human error and increasing productivity, robotics in drug discovery offers enhanced efficiency, cost-effectiveness, and scalability, driving its adoption in the pharmaceutical industry.
What restraints the growth of robotics in the drug discovery market?
“High initial investments required for deploying robotic technology”
One of the key restraints of robotics in drug discovery is the high initial investments required for deploying robotic technology. The implementation of advanced robotics systems and infrastructure involves substantial costs, including the purchase of robotic equipment, installation, maintenance, and training of personnel. These high upfront expenses can act as a barrier for smaller companies and research institutions with limited financial resources, thereby limiting the widespread adoption of robotics in drug discovery and development processes.
Segmentation: Robotics in Drug Discovery Market
The robotics in drug discovery market is segmented on the basis of type, end users, component type, and robots type.
- On the basis of end user the robotics in drug discovery market is segmented into biopharmaceutical and pharmaceutical companies and research laboratories.
- On the basis of type, the robotics in drug discovery market is segmented into traditional robots, collaborative.
- On the basis of component type, the segment of the robotics in drug discovery market is segmented into hardware, service and software.
- On the basis of robot type, the segment of robotics in drug discovery market is divided into autonomous and semi- autonomous.
Regional Insights: North America dominates the robotics in drug discovery market
North America dominates the robotics in drug discovery market due to its high market share and revenue. This dominance is expected to continue in the forecast period, driven by increased investment in research and development capabilities, which enhance the region's proficiency in drug discovery processes.
Asia-Pacific is expected to experience the highest growth rate in the robotics in drug discovery market during the forecast period. This is attributed to the region's rising government expenditure on the healthcare sector and the healthcare industry's increasing adoption of robotic technology, driving advancements in drug discovery processes.
To know more about the study visit, https://www.databridgemarketresearch.com/zh/reports/global-robotics-in-drug-discovery-market
The Prominent Key Players Operating in the Robotics in Drug Discovery Market Include:
- KUKA AG (Germany)
- YASKAWA ELECTRIC CORPORATION (Japan)
- Mitsubishi Electric Corporation (Japan)
- DENSO WAVE INCORPORATED (Japan)
- AstraZeneca (United Kingdom)
- FANUC Corporation (Japan)
- Universal Robots (Denmark)
- Nachi Robotic Systems, Inc. (U.S.)
- Rethink Robotics (U.S.)
- Robert Bosch GmbH (Germany)
- Kawasaki Heavy Industries, Ltd (Japan)
- ABB (Switzerland)
- Stäubli International AG (Switzerland)
- YASKAWA ELECTRIC CORPORATION (Japan)
- Comau S.p.A. (Italy)
- Teradyne Inc. (U.S.)
- Automatica Kassow Robots (Denmark)
- Vecna (U.S.)
- Robotiq Inc. (Canada)
- OMRON Corporation (Japan)
Above are the key players covered in the report, to know about more and exhaustive list of robotics in drug discovery market companies contact, https://www.databridgemarketresearch.com/zh/contact
Research Methodology: Global Robotics in Drug Discovery Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
